NCT04921943View on ClinicalTrials.gov

Hypertonic Saline for MAC

PHASE4RecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 18, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Nontuberculous Mycobacterial Lung DiseaseNontuberculous Mycobacterium Infection
Interventions
DRUG

Hypertonic saline

Nebulizing with 7% hypertonic saline twice daily for 12 weeks.

DRUG

Azithromycin

Standard of care

DRUG

Ethambutol

Standard of care

DRUG

Rifampin

Standard of care

Trial Locations (3)

10016

ACTIVE_NOT_RECRUITING

NYU Langone Health, New York

97239

RECRUITING

Oregon Health & Science University, Portland

ON M5G

RECRUITING

University Health Network, Toronto

All Listed Sponsors
collaborator

NTM Info & Research, Inc.

UNKNOWN

collaborator

University Health Network, Toronto

OTHER

collaborator

New York University

OTHER

lead

Oregon Health and Science University

OTHER